Humana Inc. (NYSE:HUM) Shares Sold by US Bancorp DE

US Bancorp DE decreased its position in Humana Inc. (NYSE:HUMFree Report) by 0.2% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 31,599 shares of the insurance provider’s stock after selling 52 shares during the quarter. US Bancorp DE’s holdings in Humana were worth $14,466,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also recently added to or reduced their stakes in HUM. Rakuten Securities Inc. acquired a new position in Humana in the 4th quarter valued at about $25,000. Gradient Investments LLC increased its stake in shares of Humana by 200.0% during the 4th quarter. Gradient Investments LLC now owns 60 shares of the insurance provider’s stock valued at $27,000 after acquiring an additional 40 shares during the last quarter. Cetera Trust Company N.A acquired a new position in shares of Humana during the 4th quarter valued at about $28,000. Private Wealth Management Group LLC acquired a new position in shares of Humana during the 4th quarter valued at about $32,000. Finally, Turtle Creek Wealth Advisors LLC acquired a new position in shares of Humana during the 4th quarter valued at about $55,000. Institutional investors and hedge funds own 92.38% of the company’s stock.

Analyst Ratings Changes

HUM has been the subject of a number of research analyst reports. Barclays dropped their price objective on shares of Humana from $356.00 to $310.00 and set an “equal weight” rating for the company in a research note on Tuesday, April 2nd. Jefferies Financial Group dropped their price objective on shares of Humana from $411.00 to $381.00 and set a “buy” rating for the company in a research note on Monday, April 22nd. Bank of America upped their price objective on shares of Humana from $342.00 to $376.00 and gave the company a “neutral” rating in a research note on Monday, May 20th. TD Cowen dropped their price objective on shares of Humana from $427.00 to $396.00 and set a “buy” rating for the company in a research note on Tuesday, April 2nd. Finally, Wells Fargo & Company dropped their target price on shares of Humana from $413.00 to $350.00 and set an “overweight” rating for the company in a research report on Monday, April 8th. Eleven analysts have rated the stock with a hold rating and nine have given a buy rating to the company. According to MarketBeat, Humana presently has an average rating of “Hold” and an average price target of $426.39.

Read Our Latest Analysis on Humana

Humana Stock Down 0.8 %

Shares of NYSE:HUM opened at $349.30 on Monday. The company has a quick ratio of 1.67, a current ratio of 1.67 and a debt-to-equity ratio of 0.77. Humana Inc. has a 52-week low of $298.61 and a 52-week high of $530.54. The company has a 50 day moving average of $324.36 and a two-hundred day moving average of $370.76. The company has a market capitalization of $42.09 billion, a price-to-earnings ratio of 21.75, a price-to-earnings-growth ratio of 2.03 and a beta of 0.49.

Humana (NYSE:HUMGet Free Report) last released its earnings results on Wednesday, April 24th. The insurance provider reported $7.23 EPS for the quarter, beating the consensus estimate of $6.12 by $1.11. The company had revenue of $29.61 billion during the quarter, compared to analysts’ expectations of $28.52 billion. Humana had a return on equity of 17.76% and a net margin of 1.82%. The business’s revenue was up 10.7% on a year-over-year basis. During the same period in the prior year, the business posted $9.38 EPS. As a group, analysts forecast that Humana Inc. will post 16.18 earnings per share for the current fiscal year.

Humana Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 26th. Stockholders of record on Friday, June 28th will be paid a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a dividend yield of 1.01%. The ex-dividend date is Friday, June 28th. Humana’s dividend payout ratio (DPR) is currently 22.04%.

About Humana

(Free Report)

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Featured Stories

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUMFree Report).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.